| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 03/28/2013 | WO2013042414A1 Dithienopyrrole compound, dye for photoelectric conversion element, semiconductor electrode employing same for photoelectric conversion element, and photoelectric conversion element |
| 03/28/2013 | WO2013041606A1 Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates |
| 03/28/2013 | WO2013041497A1 Substituted n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin c |
| 03/28/2013 | CA2849039A1 Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates |
| 03/28/2013 | CA2848929A1 Substituted n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin c |
| 03/27/2013 | EP2571883A1 Macrocyclic compounds as trk kinase inhibitors |
| 03/27/2013 | EP2571880A1 Pyrrolo [2, 3 - b]pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors |
| 03/27/2013 | EP2571879A1 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 03/27/2013 | EP2571503A2 Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
| 03/27/2013 | EP2571356A1 Spiro isoxazoline compounds as sstr5 antagonists |
| 03/27/2013 | CN103003281A Pyrrolo [2, 3 - b] pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors |
| 03/27/2013 | CN102993207A Rhodamine B-triazine compounds and preparation method and application thereof |
| 03/27/2013 | CN102993201A 6-(4-hydroxyl-phenyl)-3-styryl-1H-pyrazole[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitor |
| 03/27/2013 | CN101613352B Carbapenem derivatives containing formamide heterocyclic mercaptopyrrolidine |
| 03/26/2013 | US8404706 Opioid and opioid-like compounds and uses thereof |
| 03/26/2013 | US8404678 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 03/26/2013 | US8404674 Substituted 9H-purin-2-YL compounds, compositions thereof and uses thereof |
| 03/21/2013 | WO2013038650A1 Fused heterocyclic aromatic derivative, organic electroluminescence element material, and organic electroluminescence element using same |
| 03/21/2013 | WO2013038362A1 6 - substituted 3 - (quinolin- 6 - ylthio) - [1,2,4] triazolo [4, 3 -a] pyradines as tyrosine kinase |
| 03/21/2013 | CA2848809A1 6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyradines as c-met tyrosine kinase |
| 03/20/2013 | EP2570418A2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound |
| 03/20/2013 | EP2570414A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/20/2013 | CN102977126A Dual-indolizine substitutive derivative as well as preparation method and use thereof |
| 03/20/2013 | CN102977125A 2,7-naphthyridine derivative, and preparation method and application thereof |
| 03/20/2013 | CN102276800B Triphenylamine unit porphyrin copolymer as well as preparation method and application thereof |
| 03/19/2013 | US8399659 Compounds and methods for inhibiting mitotic progression |
| 03/19/2013 | US8399458 Compounds useful as protein kinase inhibitors |
| 03/19/2013 | CA2712783C Beta-lactamase inhibitors |
| 03/14/2013 | WO2013035630A1 Dye, photoelectric conversion element using same, and photoelectrochemical cell |
| 03/14/2013 | WO2013035329A1 Organic electroluminescence element |
| 03/14/2013 | WO2013033981A1 2,7-naphthyridine derivative, preparation method therefor and use thereof |
| 03/14/2013 | US20130065881 Tricyclic Compounds for Use as Kinase Inhibitors |
| 03/13/2013 | EP2566481A1 Aza-indole derivatives useful as modulators of faah |
| 03/13/2013 | EP2566479A1 Azaindazoles |
| 03/13/2013 | CN102971329A Pyrrolobenzodiazepines used to treat proliferative diseases |
| 03/13/2013 | CN102971322A Macrocyclic compounds as TRK kinase inhibitors |
| 03/13/2013 | CN102964350A 7-hexahydropyrrolo[1, 2-a]pyrazinylquinolonecarboxylic acid derivative and its application in treatment of Helicobacter pylori infections |
| 03/12/2013 | CA2699568C Azaindoles |
| 03/07/2013 | WO2013033269A1 Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same |
| 03/07/2013 | WO2013033268A2 Bivalent bromodomain ligands, and methods of using same |
| 03/07/2013 | WO2013033061A1 Fused bicyclic diamine derivatives as hiv attachment inhibitors |
| 03/07/2013 | WO2013033059A1 Spiro bicyclic diamine derivatives as hiv attachment inhibitors |
| 03/07/2013 | WO2013031931A1 Chemokine receptor activity regulator |
| 03/07/2013 | WO2013030288A1 Substituted annellated pyrimidine and the use thereof |
| 03/07/2013 | WO2013003298A3 Inhibitors of pde10 |
| 03/07/2013 | US20130059844 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 03/07/2013 | CA2847075A1 Substituted annellated pyrimidine and the use thereof |
| 03/06/2013 | EP2565194A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE |
| 03/06/2013 | EP2563795A1 Inhibitors of protein tyrosine kinase activity |
| 03/06/2013 | EP2563125A1 Azaindoles as janus kinase inhibitors |
| 03/06/2013 | CN102958930A 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer |
| 03/06/2013 | CN102952151A 3-position bis-beta-carboline alkali compound, and preparation method, pharmaceutical composition and application thereof |
| 03/06/2013 | CN102076686B Diketopiperidine derivatives as HIV attachment inhibitors |
| 03/06/2013 | CN102002060B Preparation method of cefozopran hydrochloride |
| 02/28/2013 | WO2013028818A1 Pyrimido- pyridazinone compounds and use thereof |
| 02/28/2013 | US20130053555 Organic electroluminescent devices |
| 02/28/2013 | US20130053363 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE |
| 02/28/2013 | US20130053346 Pyrimido-pyridazinone compounds and methods of use thereof |
| 02/28/2013 | CA2846187A1 Pyrimido-pyridazinone compounds and use thereof |
| 02/28/2013 | CA2844988A1 2-spiro-substituted iminothiazines and their mono- and dioxides as bace inhibitors, compositions, and their use |
| 02/27/2013 | CN101790533B Cyclopropyl fused indolobenzazepine hcv inhibitors |
| 02/26/2013 | US8383634 Methods of treatment using heteroaryl compounds and compositions thereof |
| 02/26/2013 | US8383618 C2-fluoro substituted piperazine linked pyrrolo[2,1-C][1,4] benzodiazepine dimers and a process for the preparation thereof |
| 02/21/2013 | WO2013025628A1 Janus kinase inhibitor compounds and methods |
| 02/21/2013 | WO2013024291A2 Therapeutically active fused pyrimidine derivatives |
| 02/21/2013 | WO2011101069A3 1, 8 -naphthyridines as kinase inhibitors |
| 02/20/2013 | EP2559694A2 Azaindoles useful as inhibitors of Janus kinases |
| 02/20/2013 | EP2558475A1 Pyrrolobenzodiazepines used to treat proliferative diseases |
| 02/20/2013 | EP2558469A1 Pyrrolopyrazinone inhibitors of kinases |
| 02/20/2013 | CN102939292A Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
| 02/20/2013 | CN102939290A 2,3 dihydro-1h-inden-1-yl- 2,7-diazaspiro [3.6] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor |
| 02/20/2013 | CN102936259A Method for synthesizing cucurbit [6] uril, Q[6]-rear earth linear polymer and separating light rear earth from heavy rear earth |
| 02/20/2013 | CN102936258A Cucurbit [7] uril-rare earth tubular polymer induced by tetrachloro zinc acidic group and synthetic method thereof |
| 02/20/2013 | CN102936255A Separation method for Q[5]@Q[10] |
| 02/19/2013 | CA2575473C Radicals and their use as paramagnetic agents in a dnp process |
| 02/14/2013 | WO2013023109A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (coupled tricyclic core compounds) |
| 02/14/2013 | WO2013023108A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (heteroarylene spacer moiety) |
| 02/14/2013 | WO2013023107A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (electron withdrawing groups) |
| 02/14/2013 | WO2013023106A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (acyl moieties) |
| 02/14/2013 | WO2013021315A1 Process for the preparation of benzohetero [ 1, 3 ] - diazole compounds disubstituted with heteoaryl groups |
| 02/14/2013 | US20130040978 Spiro isoxazoline compounds as sstr5 antagonists |
| 02/14/2013 | US20130040934 Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
| 02/14/2013 | US20130040933 Azaindoles as janus kinase inhibitors |
| 02/14/2013 | CA2844440A1 Process for the preparation of benzohetero[1,3]diazole compounds disubstituted with heteroaryl groups |
| 02/13/2013 | CN102933584A Pyrrolopyrazinone inhibitors of kinases |
| 02/13/2013 | CN102933583A Heteroaryl imidazolone derivatives as JAK inhibitors |
| 02/13/2013 | CN102924447A Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element |
| 02/13/2013 | CN102924384A Derivatives having vinyl group and its use in electroluminescent element |
| 02/13/2013 | CN102924367A Benzanthracene organic light-emitting material and preparation method thereof |
| 02/07/2013 | WO2013018733A1 1,5-naphthyridine derivative or salt thereof |
| 02/07/2013 | US20130035484 Intermediates useful for the synthesis of pyrrolobenzodiazepines |
| 02/06/2013 | EP2552918A1 N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as pde10a inhibitors |
| 02/06/2013 | CN102918048A Cephem compound having catechol group |
| 02/06/2013 | CN102918047A Cephem compound having pseudo-catechol group |
| 02/06/2013 | CN102918043A Pyrrolopyrimidine compounds as inhibitors of CDK4/6 |
| 02/06/2013 | CN102918042A 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds |
| 02/06/2013 | CN102911172A Heteroaryl pyrimidine derivatives and preparation method and application thereof |
| 02/06/2013 | CN101874032B Novel naphthyridine derivative monohydrate and method for producing the same |
| 02/06/2013 | CN101747352B Preparation method for biapenem condensation compound crystal |
| 01/31/2013 | US20130028917 Pyrrolobenzodiazepines and conjugates thereof |